stockrowThe Chemours Company
CC Basic Materials Specialty Chemicals
The Chemours Company’s revenue for fiscal 2025 (year ended December 2025) was $5.8 billion, roughly unchanged from fiscal 2024.
- Revenue
- +3.01%
- EPS
- +223.8%
- Free cash flow
- −12.5%
- Total debt
- −7.64%
Quarter to September 2026, against a year earlier
Follow CC
Alert me
The Chemours Company (CC) Shares outstanding
The Chemours Company's shares outstanding at the end of fiscal 2025 was $150.2M, unchanged from fiscal 2024. At the end of the quarter to 30 September 2026 it was $151.9M. Over the past ten years it has ranged from $148.9M (fiscal 2023) to $191.0M (fiscal 2017); the current reading is higher than 27% of that period. The Chemours Company ranks 15th of 59 Specialty Chemicals companies by shares outstanding.
Shares outstanding, annual
Embed this chart
Annual newest first
| Period | Shares outstanding | Change |
|---|---|---|
| FY2025 | $150.2M | 0.04% |
| FY2024 | $150.2M | 0.85% |
| FY2023 | $148.9M | (5.93%) |
| FY2022 | $158.3M | (6.16%) |
| FY2021 | $168.7M | 1.41% |
| FY2020 | $166.3M | 0.93% |
| FY2019 | $164.8M | (9.72%) |
| FY2018 | $182.6M | (4.40%) |
| FY2017 | $191.0M | 4.13% |
| FY2016 | $183.4M | 1.34% |
Quarterly newest first
| Period | Shares outstanding | Change |
|---|---|---|
| Sep 2026 | $151.9M | 0.45% |
| Jun 2026 | $151.2M | 0.30% |
| Mar 2026 | $150.8M | 0.35% |
| Dec 2025 | $150.2M | (0.36%) |
| 43 more quarters | Free account |
Against its own ten years
Shares outstanding against peers
| Company | Shares outstanding |
|---|---|
| CC The Chemours Company | $151.9M |
| FUL H. B. Fuller Company compare | $54.9M |
| NGVT Ingevity Corporation compare | $35.3M |
| MTX Minerals Technologies Inc. compare | $31.2M |
| STDN Standard Nuclear Inc compare | $28.0M |
| IOSP Innospec Inc. compare | $24.7M |
| SCL Stepan Company compare | $23.0M |
| KWR Quaker Houghton compare | $17.3M |
| WDFC WD-40 Company compare | $13.5M |
What Shares outstanding is
Shares (Diluted, Weighted) tells an investor how many shares a company’s earnings are spread across once potential new shares are counted.
Reported line item
More on CC
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement